Stay updated with breaking news from Sv Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ZWI Therapeutics, Inc. (ZWI), a biotechnology company focused on the development of protein therapeutics using proprietary new polymers,...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support ... SpyBiotechFebruary 10, 2021 GMT SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technology Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated Lutz B. Giebel joins as Chairman, strengthening governance as com...
(1) SpyBiotech has raised $32.5M from leading investors to advance development of its novel "plug and display" vaccine platform technology Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated Lutz B. Giebel joins as Chairman, strengthening governance as company expands clinical development and builds operational resource OXFORD, United Kingdom, Feb. 10, 2021 (GLOBE NEWSWIRE) -- SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infect...
Investegate announcements from SpyBiotech, SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development
Cognoptix Announces Formation of a New Board of Directors News provided by Share this article Share this article MARLBOROUGH, Mass., Dec. 30, 2020 /PRNewswire/ -- Cognoptix is a breakthrough diagnostics company developing an innovative office-based device-drug system for the early detection of Alzheimer's disease (AD). As another milestone of the Series R restart, recapitalization, and revitalization, the company named a new Board of Directors (BOD) formed under the leadership of Dr. Susanne Wilke, Ph.D., Cognoptix' new President and CEO. In addition to Dr. Wilke, the five-member board incl...